Health Condition 1: N390- Urinary tract infection, site notspecified
Conditions
Interventions
Intervention1: Sharbat -e- Bazoori Moatadil: Dose will be administered orally twice a day after meal for 7 days.
The dose will be calculated as a fraction of the adult dose of 50 ml-
2 6 yrs: 8.3 ml B
7 9 yrs: 12.5 ml BD
10 15 yrs: 18.8 ml BD
16 18 yrs: 25 ml BD.
Control Intervention1: Nitrofurantoin: 5 7 mg/kg/day orally in 4 divided doses for 7 days
Sponsors
State Unani Medical College and Hospital
Eligibility
Inclusion criteria
Inclusion criteria: Patients of both genders aged 3 to 18 years diagnosed with uncomplicated UTI. Signs and symptoms consistent with UTI (e.g., fever, dysuria, frequency, suprapubic pain,) plus a positive urine analysis (pyuria equal or more than 5 WBC per HPF or positive leukocyte esterase per nitrite) or positive urine culture (more than 105 CFU per mL for midstream clean-catch or per local diagnostic cut-offs). First episode or non-complicated recurrent UTI (equal or less than 2 episodes in past 12 months). Patient s guardian or parents willing to sign the informed consent form and follow the study protocol.
Exclusion criteria
Exclusion criteria: Complicated UTI ( e.g., pyelonephritis with systemic toxicity, urosepsis, prostatitis etc.) Structural or functional urinary tract abnormality. Recent antibiotic used ( Use of systemic antibiotics active against urinary pathogens within 48 72 hours prior to screening). Exclude culture sensitive proven Nitrofurantoin resistant cases. Patient is unsure about attending schedule regularly.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Urine Analysis and Urine cultureTimepoint: At Baseline 7th Day | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in UTI symptomsTimepoint: At Baseline 3rd Day 7th DAY 14th DAY | — |
Countries
India
Contacts
Public ContactMo Azahar
State Unani Medical College and Hospital
Outcome results
None listed